Skip to main navigation Skip to search Skip to main content

Risk, Reflexivity and the Reclassification of Medicines: The Case of Terfenadine

  • P. R. Ward
  • , P. Bissell
  • , P. R. Noyce

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)111-113
Number of pages3
JournalJournal of Social and Administrative Pharmacy
Volume16
Issue number2
Publication statusPublished - 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 10 - Reduced Inequalities
    SDG 10 Reduced Inequalities

Cite this